A double-blind comparative multicenter study of the efficacy and safety of parecoxib IV/IM [intravenous/intramuscular] 40 mg vs placebo on reducing opioids consumption following sub muscular breast augmentation surgery.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2012
At a glance
- Drugs Parecoxib; Parecoxib
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 13 Mar 2012 Location (Peru) added as reported by ClinicalTrials.gov.
- 02 Nov 2007 Status changed from initiated to withdrawn prior to recruitment.
- 17 Mar 2007 New trial record.